20/20 Biolabs, Inc.
AIDX
$0.60
$0.011.58%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 136.50% | -42.49% | -- | -- | -56.38% |
| Total Receivables | -- | 47.82% | -- | -- | -- |
| Inventory | -- | 146.19% | -- | -- | -- |
| Prepaid Expenses | -- | 90.27% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -- | -27.68% | -- | -- | -- |
|
|
|||||
| Total Current Assets | -- | -27.68% | -- | -- | -- |
| Net Property, Plant & Equipment | -- | -25.54% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -5.17% | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 845.00% | -- | -- | -- |
| Total Assets | -- | 15.43% | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | -- | 133.28% | -- | -- | -- |
| Total Accrued Expenses | -- | 126.72% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 51.24% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 18.66% | -- | -- | -- |
| Total Other Current Liabilities | -- | 18.66% | -- | -- | -- |
| Total Current Liabilities | -- | 81.77% | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | -- | 81.77% | -- | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -27.47% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 1,070.80% | -- | -- | -- |
| Total Liabilities | -- | 99.94% | -- | -- | -- |
|
|
|||||
| Common Stock & APIC | -- | 7.05% | -- | -- | -- |
| Retained Earnings | -- | -12.67% | -- | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 75.01% | -104.55% | -- | -- | -65.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 0.85% | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 336.32% | 0.85% | -- | -- | 1.30% |
|
|
|||||
| Total Common Equity | 75.01% | -104.55% | -- | -- | -65.61% |
| Total Preferred Equity | 336.32% | 0.85% | -- | -- | 1.30% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 83.14% | -101.28% | -- | -- | -64.89% |
|
|
|||||